Harnessing CD36 to Rein in Inflammation

E-ISSN： 2212-3873|8|3|184-191

ISSN： 1871-5303

Source： Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders), Vol.8, Iss.3, 2008-09, pp. : 184-191

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

CD36-TSP-HRGP Interactions in the Regulation of Angiogenesis

Current Pharmaceutical Design, Vol. 13, Iss. 35, 2007-12 ,pp. : 3559-3567

Bentham Science Publishers

Access to resources Recommend Favorite

CD36 as a Therapeutic Target for Endothelial Dysfunction in Stroke

Current Pharmaceutical Design, Vol. 18, Iss. 25, 2012-07 ,pp. : 3721-3730

Bentham Science Publishers

Access to resources Recommend Favorite

CD44 and its Role in Inflammation and Inflammatory Diseases

Inflammation & Allergy-Drug Targets (Formerly Current Drug Targets - Inflammation & Allergy), Vol. 8, Iss. 3, 2009-07 ,pp. : 208-220

Bentham Science Publishers

Access to resources Recommend Favorite

Contribution of Platelet-Derived CD40 Ligand to Inflammation, Thrombosis and Neoangiogenesis

Current Medicinal Chemistry, Vol. 14, Iss. 20, 2007-08 ,pp. : 2170-2180

Bentham Science Publishers

Access to resources Recommend Favorite

Statins upregulate CD36 expression in human monocytes, an effect strengthened when combined with PPAR- ligands Putative contribution of Rho GTPases in statin-induced CD36 expression

By Ruiz-Velasco N. Dominguez A. Vega M.A.

Biochemical Pharmacology, Vol. 67, Iss. 2, 2004-01 ,pp. : 303-313

Elsevier

Access to resources Recommend Favorite